Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Boxen

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine and Biology|May 1, 1995
Labelling small quantities of monoclonal antibodies and their F(ab')2 fragments with technetium-99mM Tesic, K M Sheldon, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Formulation of technetium-99m-aerosol colloid with improved delivery efficiency for lung ventilation imagingJ R Ballinger, T W Andrey, I Boxen, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
Nuclear Medicine Communications|April 1, 1995
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variantJ R Ballinger, H A Hua, B W Berry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitroJ R Ballinger, D S Cowan, I Boxen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cellsJ R Ballinger, J Bannerman, I Boxen, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Comparison of the iodogen and the microelectrochemical techniques for the radioiodination of monoclonal antibody 140.240Z M Wong, F W Teare, B M Bowen, et al.
Cancer|July 24, 2001
A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinomaA Bayley, M Milosevic, R Blend, et al.
Nuclear Medicine Communications|February 1, 1996
Imaging inflammation with 99Tcm-labeled chemotactic peptides: analogues with reduced neutropeniaA Pollak, A E Goodbody, J R Ballinger, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine and Biology|May 1, 1995
Labelling small quantities of monoclonal antibodies and their F(ab')2 fragments with technetium-99mM Tesic, K M Sheldon, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Formulation of technetium-99m-aerosol colloid with improved delivery efficiency for lung ventilation imagingJ R Ballinger, T W Andrey, I Boxen, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoproteinJ R Ballinger, K M Sheldon, I Boxen, et al.
Nuclear Medicine Communications|April 1, 1995
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variantJ R Ballinger, H A Hua, B W Berry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitroJ R Ballinger, D S Cowan, I Boxen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cellsJ R Ballinger, J Bannerman, I Boxen, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Comparison of the iodogen and the microelectrochemical techniques for the radioiodination of monoclonal antibody 140.240Z M Wong, F W Teare, B M Bowen, et al.
Cancer|July 24, 2001
A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinomaA Bayley, M Milosevic, R Blend, et al.
Nuclear Medicine Communications|February 1, 1996
Imaging inflammation with 99Tcm-labeled chemotactic peptides: analogues with reduced neutropeniaA Pollak, A E Goodbody, J R Ballinger, et al.
Pageof 3